ASSA ABLOY acquires Lumidigm in the US

10 Feb 2014

ASSA ABLOY has acquired Lumidigm, a leading manufacturer of biometric readers based on patented multispectral imaging technology. This technology is supported by sophisticated solutions to ensure robust biometric identification even under adverse conditions.

“Lumidigm is an important technological addition to the ASSA ABLOY Group. The Company complements our current offering within the rapidly growing biometric segment. The acquisition of Lumidigm considerably enhances the Group’s position within biometrics and will provide complementary growth opportunities,” says Johan Molin, President and CEO of ASSA ABLOY.

“Lumidigm is an exciting addition to our Secure Identity portfolio, enabling HID Global to incorporate multispectral imaging biometrics as part of our multi-factor authentication solutions for government, banking and enterprise,” says Denis Hébert, Executive Vice President ASSA ABLOY and Head of business unit HID Global.

Lumidigm was founded in 2001 and has 33 employees. The head office is located in Albuquerque, New Mexico.

Sales are expected to reach USD 25 M (approx. SEK 160 M) in 2014. The acquisition will be accretive to EPS from start.

  
For more information, please contact:

Johan Molin, President and CEO, tel no: +46 8 506 485 42
Carolina Dybeck Happe, CFO and Executive Vice President, tel no: +46 8 506 485 72


  
About ASSA ABLOY

ASSA ABLOY is the global leader in door opening solutions, dedicated to satisfying end-user needs for security, safety and convenience. Since its formation in 1994, ASSA ABLOY has grown from a regional company into an international group with around 43,000 employees, operations in over 70 countries and sales of over SEK 48 billion. ASSA ABLOY offers a more complete range of door opening solutions than any other company on the market. In the fast-growing electromechanical security segment, the Group has a leading position in areas such as access control, identification technology, entrance automation and hotel security.